INNOVIVA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.2 USD | -0.49% |
|
+0.81% | +1.00% |
| 18/06 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
| 10/06 | Transcript : Innoviva, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 01:20 PM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.02B | - | - | ||||
| 811B | ||||||
| 640B | ||||||
| 353B | - | - | - | - | ||
| 333B | ||||||
| 302B |
- Stock Market
- Equities
- INVA Stock
- Charts Innoviva, Inc.
- Sector Chart
